Avery Therapeutics

Avery Therapeutics has a platform tissue engineering technology with applications in a variety of diseases. Avery’s lead product, MyCardia™, is a tissue engineered graft for treating heart failure. MyCardia is implanted on the surface of the diseased heart to grow blood vessels and heart muscle.